References
- Marshall K. (1976). Compression and consolidation of Industrial Pharmacy. In: The theory and practice of industrial pharmacy, Lachman L, Liberman A, Kanig JL, (eds). Philadelphia, USA: Lea & Febiger. pp 66–99.
- Asker A, el-Nakeeb M, Motawi M, el-Gindy N. (1973). Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants. Pharmazie, 28:476–478.
- van der Watt JG. (1987). The effect of the particle size of microcrystalline cellulose on tablet properties in mixtures with magnesium stearate. Int J Pharm, 36:51–54.
- Bolhuis GK, Jong SW, Lerk CF. (1987). The effect of magnesium stearate admixing in different types of laboratory and industrial mixers on tablet crushing strength. Drug Dev Ind Pharm, 13:1547–1567.
- Shah AC, Mlodozeniec AR. (1977). Mechanism of surface lubrication: Influence of duration of lubricant-excipient mixing on processing characteristics of powders and properties of compressed tablets. J Pharm Sci, 66:1377–1378.
- Johansson ME, Nicklasson M. (1986). Investigation of the film formation of magnesium stearate by applying a flow-through dissolution technique. J Pharm Pharmacol, 38:51–54.
- Kikuta J, Kitamori N. (1994). Effect of mixing time on the lubricating properties of magnesium stearate and the final characteristics of the compressed tablets. Drug Dev Ind Pharm, 20:343–355.
- Kincl M, Turk S, Vrecer F. (2005). Application of experimental design methodology in development and optimization of drug release method. Int J Pharm, 291:39–49.
- Bloomfield MS, Butler WC. (2000). Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties. Int J Pharm, 206:55–61.
- Park JS, Shim JY, Nguyen KV, Park JS, Shin S, Choi YW et al. (2010). A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets. Int J Pharm, 393:79–87.
- Sako K, Nakashima H, Sawada T, Fukui M. (1996). Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs. Pharm Res, 13:594–598.
- Shin S, Choi du H, Truong NK, Kim NA, Chu KR, Jeong SH. (2011). Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles. Int J Pharm, 407:53–62.
- Vining GG, Myers RH. (1990). Combining taguchi and response surface philosophies: A dual response approach. J Qua Technol, 22:38–45.
- Shin SM, Cho BR. (2005). Bias-specified robust design optimization and an analytical solution. Comput Ind Eng, 48:129–148.
- Alderman DA. (1984). A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage forms. Int J Pharm, 5:1–9.
- Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung KC. (1996). Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J Pharm Sci, 85:732–740.
- Campos-Aldrete ME, Villafuerte-Robles L. (1997). Influence of the viscosity degree and the particle size of HPMC on metronidazole release from matrix tablets. Eur J Pharm Biopharm, 43:173–178.
- Chopra S, Patil GV, Motwani SK. (2007). Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design. Eur J Pharm Biopharm, 66:73–82.
- Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P et al. (2007). Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study. Int J Pharm, 333:143–151.
- Iranloye TA, Parrott EL. (1978). Effects of compression force, particle size, and lubricants on dissolution rate. J Pharm Sci, 67:535–539.
- Pingali K, Mendez R, Lewis D, Michniak-Kohn B, Cuitino A, Muzzio F. (2011). Mixing order of glidant and lubricant–influence on powder and tablet properties. Int J Pharm, 409:269–277.
- Pingali K, Mendez R, Lewis D, Michniak-Kohn B, Cuitiño A, Muzzio F. (2011). Evaluation of strain-induced hydrophobicity of pharmaceutical blends and its effect on drug release rate under multiple compression conditions. Drug Dev Ind Pharm, 37:428–435.
- Wang J, Wen H, Desai D. (2010). Lubrication in tablet formulations. Eur J Pharm Biopharm, 75:1–15.
- Davis SS, Hardy JG, Fara JW. (1986). Transit of pharmaceutical dosage forms through the small intestine. Gut, 27:886–892.
- Siepmann J, Streubel A, Peppas NA. (2002). Understanding and predicting drug delivery from hydrophilic matrix tablets using the “sequential layer” model. Pharm Res, 19:306–314.